The latest news, developments and research findings from all fields of science including biology, chemistry, physics, psychology, sociology and space, including news on the latest policies regulating this sector.
In the ever-evolving landscape of technological advancement, industry-academia collaboration emerges as a formidable catalyst for innovation breakthroughs.
Gwo-shyh Song, Associate Professor at the National Taiwan University and Global Aqua Survey Ltd, walks us through his high-resolution seabed geophysical survey research around offshore areas in Taiwan.
In a study of over 32,000 people, a US trial found the AstraZeneca vaccine was 100% effective against deaths caused by COVID-19 - the vaccine did not show any connection to blood clots.
Professor Heather Sheardown, C20/20 Ophthalmic Materials Innovation Hub, Department of Chemical Engineering, McMaster University, explores how polymers can be used to treat dry eye disease.
The National Center of Meteorology, who manage the UAE Research Program for Rain Enhancement Science, explain here what we need to know about advancing the science and technology of rain enhancement.
In a significant breakthrough for life science, Israeli scientists have succeeded in growing mice embryos in artificial wombs - completely outside the body.
From public health and job creation to environmental sustainability and safer communities, the social and behavioural sciences empower people everywhere to find solutions, Dr Arthur Lupia & Jason Stoughton from the U.S. National Science Foundation explain.
From 2022, Horizon Europe funding applications by public bodies, research organisations and higher education institutions will only be considered if they have a gender equality plan.
Professor Afaf El-Sagheer and Professor Tom Brown from the Department of Chemistry, Suez University and Oxford University describe their research, including the application of ‘click chemistry’ conjugation techniques to DNA.
There is a well-established diphtheria vaccine taken by millions of people, but researchers are now observing the disease evolving a resistance to antimicrobial treatment.
The US based vaccine appears to be 96.4% effective against the original COVID mutation, with 86% efficacy against the UK variant and only 55% against the South African variant.
